prescriber.co.uk ■ PRESCRIBING IN PRACTICE C hlamydia is the most common sexually-transmitted infection (STI) in the UK, with 203,116 new diagnoses in England in 2017, of which 126,828 (62%) were in young people aged 15-24 years. 1 Chlamydia is transmitted primarily through penetrative sex and infects the urethra and endocervix. It can also infect the throat and the rectum, and in some cases the conjunctiva. It is very infectious, with a concordance of up to 75% between sexual partners. There are many risk factors for chlamydia infection, including being under the age of 25 years, having a new sexual partner and inconsistent use of condoms.
If a woman contracts chlamydia during pregnancy it can be transmitted to the baby at delivery, causing conjunctivitis or pneumonia.
Classification of chlamydia infections
There are three species of chlamydia bacteria that can cause disease in humans:
• Chlamydia psittaci -the natural host is birds, especially parrots, but it can be transmitted to humans, causing psittacosis • Chlamydia pneumoniae -causes respiratory disease in humans • Chlamydia trachomatis -several different serovars can cause disease (including STIs) in humans, as detailed in Figure 1 .
Symptoms
The majority of genital chlamydia infections are asymptomatic, but they can cause significant symptoms. In women, chlamydia can cause vaginal discharge, dysuria, abdominal and pelvic pain, post-coital and intermenstrual bleeding, and deep dyspareunia. In men, chlamydia can cause dysuria, urethral irritation and urethral discharge. Rectal chlamydia is nearly always asymptomatic, but can be associated with anal discharge and discomfort. If a patient presents with proctitis then a diagnosis of lymphogranuloma venereum (LGV) should be considered.
to multiple complications. In women, it can lead to chronic pelvic pain, pelvic inflammatory disease (PID), ectopic pregnancy, tubal infertility and sexually acquired reactive arthritis (SARA). In men, it can lead to epididymo-orchitis and SARA. The cost of treating one episode of PID has been estimated to be around £163, which in London alone, with 7000 cases per year, would equate to more than £1 million a year.
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Diagnosis
The gold-standard test for chlamydia is a nucleic acid amplification test (NAAT). Enzyme immunoassay (EIA) tests are rarely performed now, as they are not as sensitive or specific as NAAT.
Asymptomatic men should be offered a first-catch urine test and asymptomatic women should be offered a vulvo-vaginal self-swab. If women are symptomatic and having a speculum examination anyway, then a cervical swab can be done, but vulvo-vaginal self-swabs have been shown to be more sensitive, even in symptomatic women. 3 It is important to remember that chlamydia can cause dysuria in both men and women, so that if a patient has a midstream specimen of urine (MSU) that shows 'sterile pyuria' then a chlamydia test should be considered.
Both rectal and throat swabs can be taken by the patient, and this can be offered for asymptomatic patients. A recent review found that rectal chlamydia in heterosexual women was common, in that 68.1% of those who had urogenital chlamydia also had rectal chlamydia, and this was not associated with reported anal intercourse. 4 Patients with proctitis should have an LGV test performed at the same time as their chlamydia test. This should be done at proctoscopy, and patients should ideally be seen in a genitourinary medicine (GUM) clinic. In addition, asymptomatic HIV-positive men who have sex with men (MSM) who have a positive chlamydia diagnosis should have a test for LGV, as they are more likely to have LGV than those who are HIV negative.
Anyone under 25 years old who is sexually active should have an annual chlamydia screen, along with a screen when changing sexual partners. Most local authorities also now offer online STI testing kits (see Box 1). The UK's National Chlamydia Screening Programme (NCSP) aims to increase early detection and control the transmission of chlamydia infection through opportunistic screening of young people (see Box 2).
Differential diagnosis
The differential diagnosis of conditions whose symptoms may resemble chlamydia is summarised in Table 1 . Most local authorities now offer online STI-testing kitsthese are self-swabs and/or urine pots, which are posted to the patient and then processed at a lab in the normal way. The results are then normally texted to the patient, with information as to where to attend for any treatment that might be indicated. This means that a patient could come to your surgery with a text message telling them that they have chlamydia.
Treatment options
First-line treatment
In 2017, 10% of chlamydia tests in those aged 15-24 years were done via an online service. 1 There have been concerns that those who do online tests will not attend for treatment, but a 2015 Cochrane review found that there was no difference between home-based and clinic-based specimen collections in the proportion of people who completed diagnosis and treatment. prescriber.co.uk daily orally for seven days. In patients who are allergic to tetracyclines, use azithromycin 1g orally as a single dose, then 500mg per day for two days.
Second-line treatment
The recommended second-line treatment options are: erythromycin 500mg twice daily for 10-14 days; or ofloxacin 200mg twice daily or 400mg once daily for seven days. 7 
HIV-positive patients
Treatment for urogenital and pharyngeal infection in HIV-positive patients remains the same as for HIV-negative patients. Rectal infection should be treated as if it were LGV (unless a negative LGV result is available) -with three weeks of doxycycline 100mg twice daily.
Pregnancy
Doxycycline and ofloxacin are contraindicated in pregnancy. Recommended treatments are either: azithromycin 1g orally as a single dose, then 500g a day for two days; or erythromycin 500mg four times daily for seven days; or erythromycin 500mg twice daily for 14 days; or amoxicillin 500mg three-times daily for seven days.
Partner notification and test of cure
Because chlamydia can be asymptomatic in so many patients, and because the complications can cause such significant morbidity, it is vital that prompt and comprehensive partner notification is undertaken for all positive diagnoses. This has traditionally been done in GUM clinics but can also be done by the GP or practice nurse, with the appropriate training.
For male patients with symptoms, all sexual partners within the four weeks preceding any symptoms and since the diagnosis should be contacted. For all other patients, all sexual partners in the six months prior to diagnosis should be contacted.
All those contacts should be tested for chlamydia and offered epidemiological treatment and a full STI screen. In addition, patients and any sexual partners should abstain from any sexual activity until treatment has been completed. This means abstaining during the week that they are taking doxycycline, or a week after completing the course of azithromycin.
A test of cure, in which you check if the treatment is working by retesting the patient, is not routinely recommended for chlamydia but one should be done three weeks after completing treatment in the following situations:
• In rectal infection if an extended course of azithromycin has been used as treatment 8 • In pregnancy • When symptoms persist • Where poor compliance or LGV is suspected.
Routine retesting should also be done three to six months after treatment in patients under the age of 25 years.
GP's role in management
GPs are well placed to screen for chlamydia, treat uncomplicated infections and undertake basic partner notification. It is also important to test for other STIs in the event that the chlamydia test is positive -a basic STI screen consists of tests for chlamydia, gonorrhoea, HIV and syphilis. While it is true that some patients would rather attend a sexual health clinic for any STI-related concerns, there is no reason why they shouldn't be able to access their GP for STI screens and treatment. Additionally, GPs should consider chlamydia (or other STIs) both as a differential diagnosis in patients with related symptoms and as a screening test in asymptomatic patients, particularly those who are under 25 years.
If a baby presents with a sticky eye within 30 days of birth, a chlamydia diagnosis should be considered. If the chlamydia This involves opportunistic screening of young people between the ages of 16 and 24 years, with the tests taking place in specialist sexual health services, GP practices and community settings. It should also include antenatal clinics (for those under 25 years) and termination services.
Box 2. National Chlamydia Screening Programme
test is then positive, it is important to remember that, alongside the baby, the mother and her partner(s) will also need to be tested and treated.
Conclusion
Chlamydia is an infection that is easily missed, but also easily treated. Due to it being an STI there are additional aspects to consider with treatment, such as partner notification and repeat testing to ensure the infection has been eradicated, but all of these things can, and should, be done by GPs where appropriate.
